anmelden
FTSE 100
10.695,25
PKT
+15,26
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 14.09.26 | Diageo Buy | Jefferies & Company Inc. | |
| 14.09.26 | BP Hold | Jefferies & Company Inc. | |
| 14.09.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 14.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 11.09.26 | BAT Underperform | RBC Capital Markets | |
| 11.09.26 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 11.09.26 | BP Buy | Goldman Sachs Group Inc. | |
| 10.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 10.09.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.09.26 | AstraZeneca Outperform | RBC Capital Markets | |
| 09.09.26 | GSK Sector Perform | RBC Capital Markets | |
| 08.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | BP Neutral | JP Morgan Chase & Co. | |
| 08.09.26 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 08.09.26 | GSK Underweight | Barclays Capital | |
| 08.09.26 | AstraZeneca Overweight | Barclays Capital | |
| 07.09.26 | Unilever Outperform | Bernstein Research | |
| 07.09.26 | Unilever Hold | Deutsche Bank AG | |
| 07.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.09.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 04.09.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.09.26 | BP Overweight | Barclays Capital | |
| 04.09.26 | Shell (ex Royal Dutch Shell) Sector Perform | RBC Capital Markets | |
| 04.09.26 | Vodafone Group Buy | Goldman Sachs Group Inc. | |
| 04.09.26 | BP Outperform | RBC Capital Markets | |
| 02.09.26 | GSK Hold | Deutsche Bank AG | |
| 02.09.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 02.09.26 | BAT Buy | UBS AG | |
| 02.09.26 | Barclays Buy | Jefferies & Company Inc. | |
| 01.09.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.09.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Diageo Neutral | JP Morgan Chase & Co. | |
| 01.09.26 | Reckitt Benckiser Group Overweight | JP Morgan Chase & Co. | |
| 01.09.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 28.08.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 28.08.26 | Diageo Outperform | Bernstein Research | |
| 25.08.26 | GSK Hold | Deutsche Bank AG | |
| 25.08.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 25.08.26 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.
